|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SLC13A3-HLA-DRB1 (FusionGDB2 ID:HG64849TG3123) |
Fusion Gene Summary for SLC13A3-HLA-DRB1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: SLC13A3-HLA-DRB1 | Fusion gene ID: hg64849tg3123 | Hgene | Tgene | Gene symbol | SLC13A3 | HLA-DRB1 | Gene ID | 64849 | 3123 |
Gene name | solute carrier family 13 member 3 | major histocompatibility complex, class II, DR beta 1 | |
Synonyms | ARLIAK|NADC3|SDCT2 | DRB1|HLA-DR1B|HLA-DRB|SS1 | |
Cytomap | ('SLC13A3')('HLA-DRB1') 20q13.12 | 6p21.32 | |
Type of gene | protein-coding | protein-coding | |
Description | solute carrier family 13 member 3Na(+)/dicarboxylate cotransporter 3hNaDC3naDC-3sodium-dependent high affinity dicarboxylate transporter 3 | major histocompatibility complex, class II, DR beta 1 precursorHLA class II histocompatibility antigen, DR-1 beta chainMHC class II HLA-DR beta 1 chainhuman leucocyte antigen DRB1lymphocyte antigen DRB1 | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | . | P01911 | |
Ensembl transtripts involved in fusion gene | ENST00000279027, ENST00000290317, ENST00000339636, ENST00000372121, ENST00000396360, ENST00000413164, ENST00000417157, ENST00000435032, ENST00000464518, ENST00000472148, ENST00000495082, | ||
Fusion gene scores | * DoF score | 2 X 2 X 1=4 | 3 X 3 X 1=9 |
# samples | 2 | 3 | |
** MAII score | log2(2/4*10)=2.32192809488736 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SLC13A3 [Title/Abstract] AND HLA-DRB1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SLC13A3(45311710)-HLA-DRB1(32557570), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | M33600 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
Top |
Fusion Gene ORF analysis for SLC13A3-HLA-DRB1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-5UTR | ENST00000279027 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000290317 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000339636 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000372121 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000396360 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000413164 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000417157 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000435032 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000464518 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000472148 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-5UTR | ENST00000495082 | ENST00000360004 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000279027 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000279027 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000279027 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000279027 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000279027 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000279027 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000279027 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000290317 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000290317 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000290317 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000290317 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000290317 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000290317 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000290317 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000339636 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000339636 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000339636 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000339636 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000339636 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000339636 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000339636 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000372121 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000372121 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000372121 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000372121 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000372121 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000372121 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000372121 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000396360 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000396360 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000396360 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000396360 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000396360 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000396360 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000396360 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000413164 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000413164 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000413164 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000413164 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000413164 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000413164 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000413164 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000417157 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000417157 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000417157 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000417157 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000417157 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000417157 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000417157 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000435032 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000435032 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000435032 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000435032 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000435032 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000435032 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000435032 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000464518 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000464518 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000464518 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000464518 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000464518 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000464518 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000464518 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000472148 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000472148 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000472148 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000472148 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000472148 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000472148 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000472148 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000495082 | ENST00000328980 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000495082 | ENST00000399450 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000495082 | ENST00000419393 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000495082 | ENST00000437784 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000495082 | ENST00000444645 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000495082 | ENST00000460546 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
intron-intron | ENST00000495082 | ENST00000553034 | SLC13A3 | chr20 | 45311710 | - | HLA-DRB1 | chr6 | 32557570 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for SLC13A3-HLA-DRB1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for SLC13A3-HLA-DRB1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:45311710/:32557570) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | HLA-DRB1 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: A beta chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the alpha chain HLA-DRA, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DRB1-restricted CD4-positive T cells. This guides antigen-specific T-helper effector functions, both antibody-mediated immune response and macrophage activation, to ultimately eliminate the infectious agents and transformed cells (PubMed:29884618, PubMed:22327072, PubMed:27591323, PubMed:8642306, PubMed:15265931, PubMed:31495665, PubMed:16148104). Typically presents extracellular peptide antigens of 10 to 30 amino acids that arise from proteolysis of endocytosed antigens in lysosomes (PubMed:8145819). In the tumor microenvironment, presents antigenic peptides that are primarily generated in tumor-resident APCs likely via phagocytosis of apoptotic tumor cells or macropinocytosis of secreted tumor proteins (PubMed:31495665). Presents peptides derived from intracellular proteins that are trapped in autolysosomes after macroautophagy, a mechanism especially relevant for T cell selection in the thymus and central immune tolerance (PubMed:17182262, PubMed:23783831). The selection of the immunodominant epitopes follows two processing modes: 'bind first, cut/trim later' for pathogen-derived antigenic peptides and 'cut first, bind later' for autoantigens/self-peptides (PubMed:25413013). The anchor residue at position 1 of the peptide N-terminus, usually a large hydrophobic residue, is essential for high affinity interaction with MHCII molecules (PubMed:8145819). {ECO:0000269|PubMed:15265931, ECO:0000269|PubMed:17182262, ECO:0000269|PubMed:22327072, ECO:0000269|PubMed:23783831, ECO:0000269|PubMed:25413013, ECO:0000269|PubMed:27591323, ECO:0000269|PubMed:29884618, ECO:0000269|PubMed:31495665, ECO:0000269|PubMed:8145819, ECO:0000269|PubMed:8642306}.; FUNCTION: Allele DRB1*01:01: Displays an immunodominant epitope derived from Bacillus anthracis pagA/protective antigen, PA (KLPLYISNPNYKVNVYAVT), to both naive and PA-specific memory CD4-positive T cells (PubMed:22327072). Presents immunodominant HIV-1 gag peptide (FRDYVDRFYKTLRAEQASQE) on infected dendritic cells for recognition by TRAV24-TRBV2 TCR on CD4-positive T cells and controls viral load (PubMed:29884618). May present to T-helper 1 cells several HRV-16 epitopes derived from capsid proteins VP1 (PRFSLPFLSIASAYYMFYDG) and VP2 (PHQFINLRSNNSATLIVPYV), contributing to viral clearance (PubMed:27591323). Displays commonly recognized peptides derived from IAV external protein HA (PKYVKQNTLKLAT and SNGNFIAPEYAYKIVK) and from internal proteins M, NP and PB1, with M-derived epitope (GLIYNRMGAVTTEV) being the most immunogenic (PubMed:8145819, PubMed:9075930, PubMed:25413013, PubMed:32668259). Presents a self-peptide derived from COL4A3 (GWISLWKGFSF) to TCR (TRAV14 biased) on CD4-positive, FOXP3-positive regulatory T cells and mediates immune tolerance to self (PubMed:28467828). May present peptides derived from oncofetal trophoblast glycoprotein TPBG 5T4, known to be recognized by both T-helper 1 and regulatory T cells (PubMed:31619516). Displays with low affinity a self-peptide derived from MBP (VHFFKNIVTPRTP) (PubMed:9075930). {ECO:0000269|PubMed:22327072, ECO:0000269|PubMed:25413013, ECO:0000269|PubMed:27591323, ECO:0000269|PubMed:28467828, ECO:0000269|PubMed:29884618, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:32668259, ECO:0000269|PubMed:8145819, ECO:0000269|PubMed:9075930}.; FUNCTION: Allele DRB1*03:01: May present to T-helper 1 cells an HRV-16 epitope derived from capsid protein VP2 (NEKQPSDDNWLNFDGTLLGN), contributing to viral clearance (PubMed:27591323). Displays self-peptides derived from retinal SAG (NRERRGIALDGKIKHE) and thyroid TG (LSSVVVDPSIRHFDV) (PubMed:25413013). Presents viral epitopes derived from HHV-6B gH/U48 and U85 antigens to polyfunctional CD4-positive T cells with cytotoxic activity implicated in control of HHV-6B infection (PubMed:31020640). Presents several immunogenic epitopes derived from C. tetani neurotoxin tetX, playing a role in immune recognition and long-term protection (PubMed:19830726). {ECO:0000269|PubMed:19830726, ECO:0000269|PubMed:25413013, ECO:0000269|PubMed:27591323, ECO:0000269|PubMed:31020640}.; FUNCTION: Allele DRB1*04:01: Presents an immunodominant bacterial epitope derived from M. tuberculosis esxB/culture filtrate antigen CFP-10 (EISTNIRQAGVQYSR), eliciting CD4-positive T cell effector functions such as IFNG production and cytotoxic activity (PubMed:15265931). May present to T-helper 1 cells an HRV-16 epitope derived from capsid protein VP2 (NEKQPSDDNWLNFDGTLLGN), contributing to viral clearance (PubMed:27591323). Presents tumor epitopes derived from melanoma-associated TYR antigen (QNILLSNAPLGPQFP and DYSYLQDSDPDSFQD), triggering CD4-positive T cell effector functions such as GMCSF production (PubMed:8642306). Displays preferentially citrullinated self-peptides derived from VIM (GVYATR/citSSAVR and SAVRAR/citSSVPGVR) and ACAN (VVLLVATEGR/ CitVRVNSAYQDK) (PubMed:24190431). Displays self-peptides derived from COL2A1 (PubMed:9354468). {ECO:0000269|PubMed:15265931, ECO:0000269|PubMed:24190431, ECO:0000269|PubMed:27591323, ECO:0000269|PubMed:8642306, ECO:0000269|PubMed:9354468}.; FUNCTION: Allele DRB1*04:02: Displays native or citrullinated self-peptides derived from VIM. {ECO:0000269|PubMed:24190431}.; FUNCTION: Allele DRB1*04:04: May present to T-helper 1 cells several HRV-16 epitopes derived from capsid proteins VP1 (HIVMQYMYVPPGAPIPTTRN) and VP2 (RGDSTITSQDVANAVVGYGV), contributing to viral clearance (PubMed:27591323). Displays preferentially citrullinated self-peptides derived from VIM (SAVRAR/citSSVPGVR) (PubMed:24190431). {ECO:0000269|PubMed:24190431, ECO:0000269|PubMed:27591323}.; FUNCTION: Allele DRB1*04:05: May present to T-helper 1 cells an immunogenic epitope derived from tumor-associated antigen WT1 (KRYFKLSHLQMHSRKH), likely providing for effective antitumor immunity in a wide range of solid and hematological malignancies. {ECO:0000269|PubMed:19120973}.; FUNCTION: Allele DRB1*05:01: Presents an immunodominant HIV-1 gag peptide (FRDYVDRFYKTLRAEQASQE) on infected dendritic cells for recognition by TRAV24-TRBV2 TCR on CD4-positive T cells and controls viral load. {ECO:0000269|PubMed:29884618}.; FUNCTION: Allele DRB1*07:01: Upon EBV infection, presents latent antigen EBNA2 peptide (PRSPTVFYNIPPMPLPPSQL) to CD4-positive T cells, driving oligoclonal expansion and selection of a dominant virus-specific memory T cell subset with cytotoxic potential to directly eliminate virus-infected B cells (PubMed:31308093). May present to T-helper 1 cells several HRV-16 epitopes derived from capsid proteins VP1 (PRFSLPFLSIASAYYMFYDG) and VP2 (VPYVNAVPMDSMVRHNNWSL), contributing to viral clearance (PubMed:27591323). In the context of tumor immunesurveillance, may present to T-helper 1 cells an immunogenic epitope derived from tumor-associated antigen WT1 (MTEYKLVVVGAVGVGKSALTIQLI), likely providing for effective antitumor immunity in a wide range of solid and hematological malignancies (PubMed:22929521). In metastatic epithelial tumors, presents to intratumoral CD4-positive T cells a KRAS neoantigen (MTEYKLVVVGAVGVGKSALTIQLI) carrying G12V hotspot driver mutation and may mediate tumor regression (PubMed:30282837). {ECO:0000269|PubMed:22929521, ECO:0000269|PubMed:27591323, ECO:0000269|PubMed:30282837, ECO:0000269|PubMed:31308093}.; FUNCTION: Allele DRB1*11:01: Displays an immunodominant HIV-1 gag peptide (FRDYVDRFYKTLRAEQASQE) on infected dendritic cells for recognition by TRAV24-TRBV2 TCR on CD4-positive T cells and controls viral load (PubMed:29884618). May present to T-helper 1 cells an HRV-16 epitope derived from capsid protein VP2 (SDRIIQITRGDSTITSQDVA), contributing to viral clearance (PubMed:27591323). Presents several immunogenic epitopes derived from C. tetani neurotoxin tetX, playing a role in immune recognition and longterm protection (PubMed:19830726). In the context of tumor immunesurveillance, may present tumor-derived neoantigens to CD4-positive T cells and trigger anti-tumor helper functions (PubMed:31495665). {ECO:0000269|PubMed:19830726, ECO:0000269|PubMed:27591323, ECO:0000269|PubMed:29884618, ECO:0000269|PubMed:31495665}.; FUNCTION: Allele DRB1*13:01: Presents viral epitopes derived from HHV-6B antigens to polyfunctional CD4-positive T cells implicated in control of HHV-6B infection. {ECO:0000269|PubMed:31020640}.; FUNCTION: Allele DRB1*15:01: May present to T-helper 1 cells an HRV-16 epitope derived from capsid protein VP2 (SNNSATLIVPYVNAVPMDSM), contributing to viral clearance (PubMed:27591323). Displays a self-peptide derived from MBP (ENPVVHFFKNIVTPR) (PubMed:9782128, PubMed:25413013). May present to T-helper 1 cells an immunogenic epitope derived from tumor-associated antigen WT1 (KRYFKLSHLQMHSRKH), likely providing for effective antitumor immunity in a wide range of solid and hematological malignancies. {ECO:0000269|PubMed:19120973, ECO:0000269|PubMed:27591323, ECO:0000269|PubMed:9782128}.; FUNCTION: Allele DRB1*15:02: Displays an immunodominant HIV-1 gag peptide (FRDYVDRFYKTLRAEQASQE) on infected dendritic cells for recognition by TRAV24-TRBV2 TCR on CD4-positive T cells and controls viral load (PubMed:29884618). May present to T-helper 1 cells an immunogenic epitope derived from tumor-associated antigen WT1 (KRYFKLSHLQMHSRKH), likely providing for effective antitumor immunity in a wide range of solid and hematological malignancies (PubMed:19120973). {ECO:0000269|PubMed:19120973, ECO:0000269|PubMed:29884618}.; FUNCTION: (Microbial infection) Acts as a receptor for Epstein-Barr virus on lymphocytes. {ECO:0000269|PubMed:11864610, ECO:0000269|PubMed:9151859}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for SLC13A3-HLA-DRB1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for SLC13A3-HLA-DRB1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SLC13A3-HLA-DRB1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | HLA-DRB1 | P01911 | DB05259 | Glatiramer | Binder | Biotech | Approved|Investigational |
Top |
Related Diseases for SLC13A3-HLA-DRB1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | C0024141 | Lupus Erythematosus, Systemic | 8 | CTD_human;ORPHANET | |
Tgene | C0003873 | Rheumatoid Arthritis | 3 | CTD_human | |
Tgene | C0027404 | Narcolepsy | 3 | CTD_human;ORPHANET | |
Tgene | C0751362 | Narcolepsy-Cataplexy Syndrome | 3 | CTD_human;ORPHANET | |
Tgene | C0005138 | Berylliosis | 2 | CTD_human | |
Tgene | C0027726 | Nephrotic Syndrome | 2 | CTD_human | |
Tgene | C0030805 | Bullous pemphigoid | 2 | ORPHANET | |
Tgene | C0033687 | Proteinuria | 2 | CTD_human | |
Tgene | C0036202 | Sarcoidosis | 2 | CTD_human;ORPHANET | |
Tgene | C2350873 | Beryllium Disease | 2 | CTD_human | |
Tgene | C0002994 | Angioedema | 1 | CTD_human | |
Tgene | C0004096 | Asthma | 1 | CTD_human | |
Tgene | C0004352 | Autistic Disorder | 1 | CTD_human | |
Tgene | C0005586 | Bipolar Disorder | 1 | PSYGENET | |
Tgene | C0009324 | Ulcerative Colitis | 1 | CTD_human | |
Tgene | C0010346 | Crohn Disease | 1 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C0011854 | Diabetes Mellitus, Insulin-Dependent | 1 | CTD_human | |
Tgene | C0013182 | Drug Allergy | 1 | CTD_human | |
Tgene | C0017665 | Membranous glomerulonephritis | 1 | CTD_human | |
Tgene | C0019193 | Hepatitis, Toxic | 1 | CTD_human | |
Tgene | C0020517 | Hypersensitivity | 1 | CTD_human | |
Tgene | C0023290 | Leishmaniasis, Visceral | 1 | CTD_human | |
Tgene | C0024301 | Lymphoma, Follicular | 1 | ORPHANET | |
Tgene | C0024302 | Reticulosarcoma | 1 | CTD_human | |
Tgene | C0024304 | Lymphoma, Mixed-Cell | 1 | CTD_human | |
Tgene | C0024305 | Lymphoma, Non-Hodgkin | 1 | CTD_human | |
Tgene | C0024306 | Lymphoma, Undifferentiated | 1 | CTD_human | |
Tgene | C0026654 | Moyamoya Disease | 1 | GENOMICS_ENGLAND | |
Tgene | C0026769 | Multiple Sclerosis | 1 | CTD_human | |
Tgene | C0029295 | Oropharyngeal Neoplasms | 1 | CTD_human | |
Tgene | C0030305 | Pancreatitis | 1 | CTD_human | |
Tgene | C0036341 | Schizophrenia | 1 | CTD_human | |
Tgene | C0041466 | Typhoid Fever | 1 | CTD_human | |
Tgene | C0042109 | Urticaria | 1 | CTD_human | |
Tgene | C0079740 | High Grade Lymphoma (neoplasm) | 1 | CTD_human | |
Tgene | C0079741 | Lymphoma, Intermediate-Grade | 1 | CTD_human | |
Tgene | C0079747 | Low Grade Lymphoma (neoplasm) | 1 | CTD_human | |
Tgene | C0079757 | Diffuse Mixed-Cell Lymphoma | 1 | CTD_human | |
Tgene | C0079770 | Lymphoma, Small Noncleaved-Cell | 1 | CTD_human | |
Tgene | C0085179 | Eosinophilia-Myalgia Syndrome | 1 | CTD_human | |
Tgene | C0086445 | Idiopathic Membranous Glomerulonephritis | 1 | CTD_human | |
Tgene | C0087031 | Juvenile-Onset Still Disease | 1 | ORPHANET | |
Tgene | C0156147 | Crohn's disease of large bowel | 1 | CTD_human | |
Tgene | C0205734 | Diabetes, Autoimmune | 1 | CTD_human | |
Tgene | C0242380 | Libman-Sacks Disease | 1 | CTD_human | |
Tgene | C0267380 | Crohn's disease of the ileum | 1 | CTD_human | |
Tgene | C0342302 | Brittle diabetes | 1 | CTD_human | |
Tgene | C0678202 | Regional enteritis | 1 | CTD_human | |
Tgene | C0751324 | Multiple Sclerosis, Acute Fulminating | 1 | CTD_human | |
Tgene | C0751622 | Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related | 1 | CTD_human | |
Tgene | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human | |
Tgene | C0949272 | IIeocolitis | 1 | CTD_human | |
Tgene | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human | |
Tgene | C1384600 | Systemic onset juvenile chronic arthritis | 1 | ORPHANET | |
Tgene | C1527304 | Allergic Reaction | 1 | CTD_human | |
Tgene | C1704378 | Heymann Nephritis | 1 | CTD_human | |
Tgene | C2349952 | Oropharyngeal Carcinoma | 1 | CTD_human | |
Tgene | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human | |
Tgene | C3714542 | Lymphoma, Diffuse | 1 | CTD_human | |
Tgene | C3837958 | Diabetes Mellitus, Ketosis-Prone | 1 | CTD_human | |
Tgene | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human | |
Tgene | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human | |
Tgene | C4554117 | Diabetes Mellitus, Sudden-Onset | 1 | CTD_human | |
Tgene | C4706583 | Limbic encephalitis with leucine-rich glioma-inactivated 1 antibodies | 1 | ORPHANET | |
Tgene | C4721532 | Lymphoma, Non-Hodgkin, Familial | 1 | CTD_human |